Worth Venture Partners’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-2,824
| Closed | -$398K | – | 131 |
|
|
2020
Q4 | $398K | Sell |
2,824
-2,297
| -45% | -$324K | 0.32% | 64 |
|
|
2020
Q3 | $571K | Buy |
5,121
+206
| +4% | +$23K | 0.47% | 51 |
|
|
2020
Q2 | $550K | Sell |
4,915
-2,129
| -30% | -$238K | 0.27% | 55 |
|
|
2020
Q1 | $545K | Buy |
7,044
+972
| +16% | +$75.2K | 0.34% | 41 |
|
|
2019
Q4 | $578K | Buy |
6,072
+187
| +3% | +$17.8K | 0.28% | 45 |
|
|
2019
Q3 | $449K | Sell |
5,885
-3,306
| -36% | -$252K | 0.26% | 46 |
|
|
2019
Q2 | $806K | Buy |
9,191
+1,398
| +18% | +$123K | 0.45% | 31 |
|
|
2019
Q1 | $705K | Sell |
7,793
-201
| -3% | -$18.2K | 0.39% | 30 |
|
|
2018
Q4 | $573K | Buy |
7,994
+2,178
| +37% | +$156K | 0.43% | 36 |
|
|
2018
Q3 | $558K | Sell |
5,816
-89
| -2% | -$8.54K | 0.42% | 34 |
|
|
2018
Q2 | $562K | Sell |
5,905
-1,313
| -18% | -$125K | 0.46% | 30 |
|
|
2018
Q1 | $633K | Sell |
7,218
-134
| -2% | -$11.8K | 0.55% | 37 |
|
|
2017
Q4 | $624K | Sell |
7,352
-966
| -12% | -$82K | 0.69% | 39 |
|
|
2017
Q3 | $720K | Sell |
8,318
-2,916
| -26% | -$252K | 0.62% | 32 |
|
|
2017
Q2 | $867K | Sell |
11,234
-2,058
| -15% | -$159K | 0.75% | 25 |
|
|
2017
Q1 | $922K | Buy |
+13,292
| New | +$922K | 0.81% | 23 |
|